Complete PRPH Stock Valuation Analysis
Comprehensive intrinsic value analysis using 1 different methodologies
PRPH Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 11 peer companies in Healthcare
P/E Ratio
$-20.36
-5328.4%
Peer Median: 7.8x
EV/EBITDA
$0.94
+140.1%
Peer Median: 2.6x
P/S Ratio
$1.41
+262.9%
Peer Median: 8.7x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for PRPH's business model and current situation.
Multiple Comparison
| Multiple | PRPH Current | Peer Median | Peer Average | Premium/Discount | Assessment |
|---|---|---|---|---|---|
| P/E Ratio | -0.1x | 7.8x | 23.3x | -101.9% | Undervalued |
| EV/EBITDA | 2.7x | 2.6x | 16.3x | 3.2% | Fair Value |
| P/S Ratio | 2.4x | 8.7x | 6.4x | -72.4% | Undervalued |
Peer Companies
Click any company to view their valuation
| Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
|---|---|---|---|---|
| $0.01B | 0.0x | 0.0x | 8.7x | |
| $0.02B | 0.0x | 0.0x | 27.3x | |
| $0.02B | 0.0x | 0.0x | 0.0x | |
| $0.02B | 0.0x | 0.0x | 0.0x | |
| $0.02B | 0.0x | 0.0x | 33.7x | |
| $0.02B | 0.8x | 2.6x | 2.4x | |
| $0.02B | 0.0x | 0.0x | 0.0x | |
| $0.01B | 7.8x | 1.5x | 0.1x | |
| $0.01B | 0.0x | 0.0x | 0.0x | |
| $0.01B | 0.0x | 0.0x | 0.0x | |
| $714.38B | 61.1x | 44.7x | 14.6x |